Research Articles

Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 DALYs and HALE Collaborators

Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.

Day E, Hellard M, Treloar C, Bruneau J, Martin NK, Øvrehus A, Dalgard O, Lloyd A, Dillon J, Hickman M, Byrne J, Litwin A, Maticic M, Bruggmann P, Midgard H, Norton B, Trooskin S, Lazarus JV, Grebely J, International Network on Hepatitis in Substance Users (INHSU)

Multiplicity of Infection Is a Poor Predictor of Village-Level <i>Plasmodium vivax</i> and <i>P. falciparum</i> Population Prevalence in the Southwest Pacific.

Koepfli C, Waltmann A, Ome-Kaius M, Robinson LJ, Mueller I

Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.

Curtis M, Dietze P, Aitken C, Kirwan A, Kinner SA, Butler T, Stoové M

Iron deficiency during pregnancy is associated with a reduced risk of adverse birth outcomes in a malaria-endemic area in a longitudinal cohort study.

Fowkes FJI, Moore KA, Opi DH, Simpson JA, Langham F, Stanisic DI, Ura A, King CL, Siba PM, Mueller I, Rogerson SJ, Beeson JG

Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C.

Heath K